Scarica l'app Stockscreener
50.37
0.04%
-0.02
Dopo l'orario di chiusura:
50.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Qiagen Nv Borsa (QGEN) Ultime notizie
Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Qiagen N.V. : Deutsche Bank reaffirms its Buy rating - www.marketscreener.com
JPMorgan Downgrades Qiagen NV (QGEN) to Neutral - StreetInsider
Qiagen N.V. : Reduced to Neutral by JP Morgan - marketscreener.com
7 Firms Advise EQT, Qiagen On $12.1B Take-Private Deal - Law360
Qiagen Agrees to EUR10.8 Billion Takeover by EQT - marketscreener.com
QIAGEN reports preliminary Q3 2026 results - The National Law Review
EQT to buy molecular testing firm Qiagen for $10.8 billion - Reuters
EQT to Acquire Qiagen for About €9.6 Billion - Briefs Finance
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer - Voice of Alexandria
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer - Business Wire
QIAGEN N.V. (QIA) Agrees To €46.50/Share Cash Tender Offer From EQT - TradingView
QIAGEN N.V. (QIA) Agrees to €46.50/Share Takeover; Q3 Sales $548M, EPS $0.65 - TradingView
QIAGEN N.V.: Conclusion of a Business Combination Agreement with EQT Private Equity; preliminary Q3 2026 results and suspension of full-year 2026 outlook - TradingView
QIAGEN N.V. (QIA) Agrees to €46.50/Share EQT Tender; Suspends FY26 Outlook - TradingView
QIAGEN N.V. (QIA) Gets €46.50/Share Cash Takeover Offer Backed by EQT - TradingView
EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen - Bloomberg.com
Qiagen N.V. Stock 12‑Month Price Target Cut to $47.57, Implies 2% Upside - TradingView
Qiagen shares surge on report of advanced EQT takeover talks - Yahoo Finance
EQT Is in Advanced Talks to Buy Testing Firm Qiagen - Bloomberg.com
QIAGEN N.V. (NYSE:QGEN) Sets Up for a Technical Breakout - ChartMill
Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.
Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
QIAGEN N.V. (QIA): BlackRock Discloses 12.91% Voting Rights - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) Notes AFM Filing on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Disclosure on BlackRock Voting Rights - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. Stock 12‑Month Price Target Raised to $47.5, Implies 7% Upside - TradingView
Qiagen stock gains 0.39 percent after-hours to EUR 40.74 - AD HOC NEWS
Qiagen stock gets a new AI growth story from QIAGEN - AD HOC NEWS
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery - BioSpace
QIAGEN N.V. (QIA) Notes AFM Disclosure on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA): BlackRock Notifies 13.04% Voting Rights - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) Receives AFM Notice on BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Discloses BlackRock 12.90% Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Disclosure on BlackRock Voting Rights - TradingView
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery - Business Wire
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
Europe Point of Care Diagnostics Market Size and Forecast, 20212031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR - GlobeNewswire Inc.
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.
Qiagen NV (CEUX:QIAD) Shiller PE Ratio : (As of Oct. 03, 2026) - GuruFocus
QIAGEN N.V. (QIA): Bank of America Holds 4.95% Voting Rights - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) AFM Discloses Bank of America Voting Rights Notice - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN jumps as new FDA clearance bolsters its syndromic-testing growth story - Quiver Quantitative
0.80%
5.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):